Comparing Fycompa vs Onfi
Fycompa (perampanel) | Onfi (clobazam) |
|
---|
Fycompa (perampanel) | Onfi (clobazam) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Epilepsy, Seizures. Fycompa may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lennox-Gastaut Syndrome. Onfi may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Fycompa (perampanel) | More about Onfi (clobazam) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Fycompa has an average rating of 5.9 out of 10 from a total of 67 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 39% reported a negative effect. |
Onfi has an average rating of 5.0 out of 10 from a total of 11 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Fycompa side effects |
View all Onfi side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Fycompa prices |
View all Onfi prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
Other clobazam brands include: Sympazan | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
105 hours |
82 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 332 drugs are known to interact with Fycompa:
|
A total of 521 drugs are known to interact with Onfi:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
October 22, 2012 |
October 21, 2011 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.